The invention relates to compounds of the formula (VIII) wherein the moieties R1, R2, R3, R4, and R5 are as defined in the specification, and salts thereof, as well as their use, methods of use for them, methods of their synthesis, and the like. The compounds are protein tyrosine kinase inhibitors and can be used in the treatment of various cancer diseases and cancer-associated pain.
该发明涉及公式(VIII)中的化合物,其中基团R1、R2、R3、R4和R5如规范中定义的那样,以及它们的盐,以及它们的使用,使用方法,合成方法等。这些化合物是
蛋白酪氨酸激酶抑制剂,可用于治疗各种癌症和与癌症相关的疼痛。